East Bay aging-focused drug company lands new partner, potential half-billion-dollar payout
The Richmond company (Nasdaq: BIOA) will get a fraction of the money upfront from Novartis (NYSE: NVS) — up to $20 million, ...
KalVista: Potential First With Multiple Sebetralstat Regulatory Reviews In 2025
KalVista has an estimated pro forma cash balance of $292.2 million, which is expected to fund its operations into the 2H of ...
Weight loss drugs could help end obesity - but risks remain, WHO says
LONDON - A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the ...
cnbctv188h
Lupin receives FDA approval for generic HIV tablets
Lupin is one of the first companies to receive approval for this formulation originally developed by Gilead Sciences, making ...
manilatimes10h
Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome
This is the third Rare Pediatric Disease Designation for relutrigine, adding to those granted for SCN2A and SCN8A DEEs Praxis ...
Neurizon Files IND Application to Support HEALEY ALS Platform Trial
(ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to announce the filing of an Investigational New Drug ...
Neurizon files key IND application with US FDA for motor neurone disease drug
Pending FDA clearance of the IND application, Neurizon said it anticipated Massachusetts General Hospital filing a protocol ...
Taiwan News23h
Artificial Intelligence For Drug Development and Discovery Market Supply Chain Key Components and Opportunities
The global market for Artificial Intelligence For Drug Development and Discovery Market has witnessed rapid growth, escalating from a valuation of $520 million in 2019 to a projected $4,815 million by ...